NOVEL USE OF TRITOQUALINE FOR THE TREATMENT OF INFLAMATORY DISEASES DIGESTIVE AND MORE PARTICULARLY GASTRIC AND ESOPHAGEAL

摘要

The invention concerns the novel use of chemical substances, the levogyrous and dextrogyrous enantiomers of (AMINO-7 TRIETHOXY-4, 5, 6 OXO-1 DIHYDRO-1, 3 ISOBENZOFURANNYL-3) -1METHOXY-8 METHYL-2METHYLENEDIOXY-6, 7TETRAHYDRO-, 2, 3, 4ISOQUINOLINE or tritoqualine, in inflammatory pathologies relating to the digestive sphere and more particularly gastric diseases.